Leika Medical Equipments Ltd. has been acquired by Angus Capital
The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.
Leika Medical Equipments Ltd. is a family-owned business specializing in the distribution and rental of wound care and pain relief products. The company provides high-end therapeutic equipment compliant with the established standards.
Angus Capital is a Canadian private equity fund specializing in the acquisition of SMEs in traditional industries. Its team is led by a group of multidisciplinary entrepreneurs who are actively involved in executing the growth plans of the companies in which they invest.
Oaklins’ team in Canada advised the shareholders of Leika on the sale of the business to Angus Capital.
Jean-Francois Tanguay
Shareholder, Leika Medical Equipments Ltd.
联系交易团队
相关交易
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
更多信息Mark Climate Technology has acquired Heber GmbH
Heber GmbH has been acquired by Mark Climate Technology, a specialist in climate control systems and a portfolio company of Bolster Investment Partners. This partnership strengthens the positions of both companies in the global market for innovative and sustainable climate solutions, as well as creating unique synergies. Mark Climate's expertise in standardized, scalable solutions is enhanced by Heber's emphasis on customer-specific customization.
更多信息Grupo Veta 2017 S.L. has been acquired by MSA Mizar
The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.
更多信息